Skip to search.
 FTSE 100 Down 1.27%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
1.72 Down 0.05(2.82%) 29 Apr 21:00
|After Hours: : 1.72 0.00 (0.00%) 29 Apr 21:55
Prev Close:1.77
Open:1.79
Bid:1.72 x 100
Ask:1.75 x 300
1y Target Est:3.00
Beta:1.44649
Earnings Date:9 May - 13 May (Est.)
Day's Range:1.72 - 1.80
52wk Range:1.30 - 5.12
Volume:1,983,630
Avg Vol (3m):2,009,210
Market Cap:417.74m
P/E (ttm):N/A
EPS (ttm):-0.45
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ARNA at this time.

Comparison

Symbol% ChgMkt Cap
ARNADown 2.82%417.74m
OREXDown 4.20%65.07m
GSKDown 1.04%103.84b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.39
Quarterly EPS Est (Mar-16) :-0.10
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.22

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors to address unmet medical needs in the United States and South Korea. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback